In this study, we aimed to evaluate the association of asymptomatic optic nerve demyelinating lesion in patients presenting a clinically isolated syndrome with the asymptomatic retinal neuro-axonal loss previously reported at clinically isolated syndrome. We prospectively recruited 66 patients presenting a clinically isolated syndrome and 66 healthy control subjects matched according to age and gender. All patients underwent brain magnetic resonance imaging including 3D-double inversion recovery (DIR) sequence, optical coherence tomography examination and visual function evaluation, at 2.5-4.5 months after CIS. Evaluation criteria were presence and length of optic nerve DIR hypersignal, retinal layers (including ganglion cell inner plexiform layer and inner nuclear layer) thickness/volume, and low contrast monocular vision acuity (number of letters correctly identified). All clinically isolated syndrome eyes with past history of optic neuritis (CIS-ON) presented an optic nerve DIR hypersignal. We observed asymptomatic optic nerve DIR hypersignal in 22.2% of clinically isolated syndrome eyes without optic neuritis (CIS-NON). Among CIS-NON, macular ganglion cell inner plexiform layer volume decrease was associated with asymptomatic optic nerve DIR hypersignal independently of optic radiations T 2 lesions and primary visual cortex volumes (P = 0.012). Symptomatic optic nerve DIR hypersignal were significantly longer (13.8 AE 6.7 mm) than asymptomatic optic nerve hypersignal (10.0 AE 5.5 mm; P = 0.047). Length of optic nerve DIR hypersignal was significantly associated with thinner inner retinal layers (P 4 0.001), thicker inner nuclear layer (P = 0.017) and lower low contrast monocular vision acuity (P 5 0.05). Compared to healthy control, low contrast monocular vision acuity was significantly lower in CIS-ON eyes (P 5 0.0001) and CIS-NON eyes with (P = 0.03) or without asymptomatic optic nerve DIR hypersignal (P = 0.0005). Asymptomatic demyelinating optic nerve DIR hypersignal at the earliest clinical stage of multiple sclerosis is frequent and associated with asymptomatic retinal neuro-axonal loss reported at clinically isolated syndrome stage. Length of optic nerve DIR hypersignal is a biomarker of retinal neuro-axonal loss and visual disability at clinically isolated syndrome stage. Visual disability of clinically isolated syndrome eyes without clinical and subclinical optic nerve involvement might be due to missed optic nerve lesions on MRI. At the earliest clinical stage of multiple sclerosis, our results support considering optical coherence tomography as a window to the optic nerve rather than to the brain. Abbreviations: CIS = clinically isolated syndrome; CIS-DIR positive = CIS with optic nerve DIR hypersignal; CIS-ON/NON = CIS with/without clinical episode of optic neuritis; CIS-NON-DIR positive/negative = CIS without clinical episode of optic neuritis and with/ without asymptomatic optic nerve DIR hypersignal; DIR = direct inversion recovery; LCMVA = low contrast monocular visual acuity; mGCIPL = macular ganglion cell layer plus inner plexiform layer; OCT = optical coherence tomography; pRNFL = peripapillary retinal nerve fibre layer
Introduction
In multiple sclerosis, peripapillary retinal nerve fibre layer (pRNFL), macular inner retinal layers atrophy, and inner nuclear layer thickening is classically described after the occurrence of a clinical episode of optic neuritis, but not always. Without past history of clinical optic neuritis, atrophy may also be found and predominates at the temporal quadrant of the pRNFL and on the macular inner retinal layers as ganglion cell layer and inner plexiform layer atrophy (Petzold et al., 2017) . The retinal neuroaxonal loss is the consequence of a degenerative process occurring all along the optic ways from the retina to the primary visual cortex. In multiple sclerosis, this degenerative process may be secondary to clinical or subclinical demyelinating lesions on the optic ways, and be predictive of risk of disability worsening (Martinez-Lapiscina et al., 2016) . At the earliest clinical stage of multiple sclerosis-clinically isolated syndrome (CIS)-presence and cause of retinal neuro-axonal loss remain debated (Trip et al., 2005; Outteryck et al., 2009; Kallenbach et al., 2011; Gelfand et al., 2012; Oreja-Guevara et al., 2012; Oberwahrenbrock et al., 2013; Pérez-Rico et al., 2014; Knier et al., 2016a; Puthenparampil et al., 2017; Zimmermann et al., 2018) .
Optic nerve imaging is challenging but remains a performing tool to detect optic nerve involvement in demyelinating diseases. The best diagnostic strategy to detect acute optic neuritis lesion is currently by using T 2 -weighted magnetic resonance sequences, including both fat and water suppression (Gass et al., 1996; Jackson et al., 1998; Kolappan et al., 2009) , because of inherent artefacts surrounding the optic nerve due to the perineural CSF and the orbital fat. Short-TI inversion recovery (STIR)-FLAIR, spectral pre-saturation inversion recovery (SPIR)-FLAIR (Jackson et al., 1998) , double inversion recovery (DIR) (Hodel et al., 2014) and DIXON multiecho MRI sequences (Smith et al., 2017) combine fat and water suppression. We showed previously that the diagnostic accuracy of 3D-DIR MRI sequence for the detection of optic nerve signal abnormalities in patients with optic neuritis was higher than coronal 2D-STIR-FLAIR MRI sequence (Hodel et al., 2014) . Contrary to a recent study (Puthenparampil et al., 2017) , we and others reported a high proportion of multiple sclerosis patients with asymptomatic optic nerve hypersignal detected on 3D-DIR MRI sequence (Hadhoum et al., 2016; Sartoretti et al., 2017) . Additionally, we showed that the length of optic nerve DIR hypersignal measured on 3D-DIR sequence in eyes previously affected by a clinical episode of optic neuritis (idiopathic optic neuritis, multiple sclerosis, neuromyelitis optica spectrum disorders) was correlated to visual disability and retinal neuro-axonal loss (Hadhoum et al., 2016) . In a study evaluating optic nerve involvement in a CIS cohort with optic neuritis, the presence of asymptomatic optic nerve hypersignal detected on STIR sequence was observed in 20% of asymptomatic nerves (Miller et al., 1988) . However, these data were not collected closely to the CIS (Miller et al., 1988) . At 3 months after CIS, we reported presence of asymptomatic optic nerve DIR hypersignal in one-third of patients (London et al., 2018) . However, the relationship of asymptomatic optic nerve demyelinating lesion with retinal thickness is not known. The aim of our study focused on a larger cohort and combined optic nerve and retinal imaging to evaluate at the earliest clinical stage of multiple sclerosis, the association of asymptomatic optic nerve involvement with the asymptomatic retinal neuroaxonal loss previously reported at the CIS stage.
Materials and methods

Population
This is a prospective cohort study conducted between June 2013 and July 2017, in Lille University Hospital (France). Included patients presented a CIS in the previous 2.5-4.5 months. All patients were followed at the Lille multiple sclerosis centre (France), had a diagnosis work-up including standard brain AE spinal cord MRI, lumbar puncture, and a complete comprehensive work-up at onset to rule out mimickers of multiple sclerosis. CIS patients developing clinically definite multiple sclerosis soon after their CIS and before inclusion period were excluded. Data on sex, age at CIS onset, type of onset and presence of oligoclonal bands were collected.
Each patient underwent clinical examination, optical coherence tomography (OCT), visual function measurement, and brain and optic nerve MRI. No patient was treated at the time of clinical/MRI/OCT evaluation. This study (CINOCIS; NCT03541226) was approved by our local ethical committee of CHRU of Lille. Written informed consent was obtained for all participants. Subjects' consent was obtained according to the Declaration of Helsinki. Consenting adults (18-65 years) diagnosed with history of CIS (44.5 months) were prospectively recruited. Subjects with other retinal pathology (e.g. glaucoma, uveitis, surgery, traumatism) or severe ametropia (56 dioptres) were excluded. Clinical examination, OCT and MRI were performed on the same day. Inclusion in the CINOCIS study is still ongoing and a first preliminary analysis focusing on multiple sclerosis diagnostic criteria has been published recently (London et al., 2018) . The present study focuses on another area and presents further analyses on an enlarged CINOCIS cohort.
For OCT analysis, all our CIS patients were matched (1:1) to healthy control subjects according to age and gender. Healthy controls were selected from our local healthy control OCT database and were randomly matched to each CIS patient using the global optimal matching algorithm (Outteryck et al., 2015) .
MRI
Each patient underwent both brain and spinal cord MRI at 3.15 (2.5-4.5) months after CIS. In our analysis, we did not consider the previous standard brain AE spinal cord MRI performed during the diagnosis work-up.
Brain and spinal cord MRI were performed on a 3-T MRI (Achieva; Philips). The brain imaging protocol (32-channel array head coils) included: 3D-T 1 -FFE (gradient echo), 3D-FLAIR, 3D-DIR and 3D-T 1 -TSE (turbo spin echo) with gadolinium. The spinal cord imaging protocol included: sagittal T 1 -TSE and T 2 -SPAIR (spectral attenuated inversion recovery). MRI parameters of 3D-DIR were as follows: sagittal acquisition, voxel size (1.2 Â 1.2 Â 0.65 mm), repetition time = 5500, echo time = 252, inversion time dual 625/2600, number of excitations = 2, fat suppression SPIR, matrix size 208 Â 208, field of view = 250 Â 250 Â 195, number of slices = 300, Sense 2. During the 3D-DIR acquisition, patients were asked to close their eyes and avoid eye movements as much as possible. Optic nerves were studied on 3D-DIR images (using post-acquisition processing: multi-planar, maximum intensity projection). For each optic nerve, the presence/absence, the number and the total length of DIR hypersignal were recorded. If a patient presented several hyperintensities on optic nerve, we would sum up the different lengths. MRI images were anonymized and were interpreted independently by two trained examiners, F.L. and O.O., with 5 and 10 years of expertise in neuroimaging of demyelinating disorders, respectively; intra-and inter-observer agreement for detection of optic nerve lesion on 3D-DIR had been evaluated previously and was excellent (Hodel et al., 2014; Hadhoum et al., 2016) . Discordant results were reconsidered to reach a consensus. After reaching consensus, length of optic nerve DIR hypersignal was measured by one experienced reader (O.O.). Inter-observer agreement for the measurement of optic nerve DIR hypersignal lesion length had been previously evaluated and was very good (Hadhoum et al., 2016) . We analysed all the visual pathways. We collected the affected optic nerve segments (orbital, canalicular, pre-chiasmatic) according to 3D-DIR sequence, checked if there was chiasmal or optic tracts involvement according to 3D-DIR and -FLAIR sequences, and measured volumes of T 2 lesions within the optic radiations, and the primary visual cortex. For each patient, we recorded the presence/absence of T 2 -weighted lesions in each of the four anatomical areas for demyelinating multiple sclerosis lesions, the presence/absence of gadolinium-enhancing lesions and the presence/absence of oligoclonal bands in CSF (Thompson et al., 2018) .
Primary visual cortex (V1) was automatically segmented on 3D-T1-FFE sequence with the FreeSurfer 5.3.0 Õ software (http://surfer.nmr.mgh.harvard.edu/), and manually corrected if necessary. The primary visual cortex volume was measured as the sum of left and right V1. Brain T 2 lesions were segmented on 3D-FLAIR with a semi-automatic method [ITKSNAP 3.6 .0 software (www.itksnap.org)]. T 2 lesion volume within bilateral optic radiations was identified with the Jü lich histological atlas warped from the Montreal Neurological Institute space to the patient 3D-FLAIR space. Each volume (V1, T 2 lesions within bilateral optic radiations) were normalized in relation to the intracranial volume.
Optical coherence tomography
OCT examination was performed with a Spectral Domain-OCT (Spectralis Õ , Heidelberg Engineering) on the same day as the MRI. Our OCT protocol included a peripapillary scan for measuring pRNFL [12 , 3.4 mm circular scan around the optic nerve with a minimum of 50 automatic real time (ART)] respecting OSCAR-IB criteria and a macular scan consisting of 25 vertical scans centred on the fovea (minimum of 25 ART). A macular segmentation was performed with HEYEX software version (multilayer segmentation algorithm, Heidelberg Engineering, version 6.0.0.3) in an anonymized manner. The mean volume [Early treatment diabetic retinopathy study (ETDRS) 3 mm perifovea rim] was calculated for the most representative macular layers represented by the macular ganglion cell layer coupled to macular ganglion cell inner plexiform layer (mGCIPL) and the macular inner nuclear layer. OCT analysis also included measurement of global and temporal pRNFL thickness. [The temporal peripapillary quadrant is injured early after clinical episode of optic neuritis (Costello et al., 2006) and more specifically thinned in multiple sclerosis (Outteryck et al., 2015; Petzold et al., 2017) .] OCT analysis was performed by an experienced OCT reader (O.O.).
Visual function
At the time of OCT, we collected the low contrast monocular visual acuity (LCMVA) with the best available correction if needed (2.5% Precision Vision ETDRS charts). The LCMVA was estimated by the number of letters correctly identified by the patient. Visual function measurement was performed by technicians without knowing the patients' clinical history. ] were compared with retinal thicknesses and volumes in their matched control eyes using linear mixed models including group (case/control status) as fixed effect, and patients and matched sets as random effects to take into account the correlation between eyes in the same patient and the matched design. We also used linear mixed models to compare retinal thicknesses and volumes between case subgroup eyes by including case subgroups as fixed effect, and patients as random effect.
Statistical analysis
Comparison in CIS-NON eyes according to the presence of optic nerve DIR hypersignal lesions were further adjusted for T 2 lesions and primary visual cortex volumes to take into account the possible contribution of brain lesions (including as fixed effects into linear mixed models). In CIS-NON-DIR positive eyes, we compared retinal thickness and volume parameters according to each segment involved using bivariate linear mixed models, and compared distribution of symptomatic optic nerve DIR hypersignal according to each segment involved using chi-squared test.
Finally, we assessed the associations of length of optic nerve DIR hypersignal with retinal neuro-axonal loss and visual function parameters also using linear mixed models with patient as random effect and length of optic nerve DIR hypersignal as fixed effect; retinal neuro-axonal loss and visual function parameters were considered as dependent variables. For all linear mixed models, normality of model residuals was checked by using the normal probability plot. We did not correct for multiple comparisons given the sample size and the exploratory nature of this study. Statistical testing was done at 2-tailed -level of 0.05. Data were analysed with SAS version 9.4 (SAS Institute, Cary, NC).
Data availability
The data that support the findings of this study are available from the corresponding author, upon reasonable request.
Results
Population
By July 2017, we had recruited 67 patients with CIS. One of them was excluded because of unilateral congenital anophthalmos. We included 66 patients with CIS matched to 66 healthy control subjects according to age and gender. Demographic characteristics of the patients (n = 66) and time elapsed between CIS and inclusion in the study are summarized in Table 1 . Patients were included at 3.15 months (2.5-4.5) after CIS [median (range)]. Twenty-two patients (33.3%) presented a clinical episode of optic neuritis as a CIS. Two (3.0%) presented bilateral optic neuritis. Screening for anti-AQP4 and anti-MOG antibodies were negative for these two patients. Others patients presented a clinical episode of non-extensive myelitis (n = 22; 33.3%), brainstem syndrome (n = 15; 22.7%) and other (n = 9; 13.6%). Two patients (3.0%) had a polysymptomatic presentation. Forty-three patients (65.2%) were female. Sex ratio (female:male) was 1. 
MRI and optical coherence tomography findings
MRI quality of 3D-DIR sequence was good without any significant ocular motion or susceptibility artefact. All OCT scans met the OSCAR-IB QC criteria.
Description of CIS eyes subgroups
Among all CIS eyes (n = 132; Fig. 1B 
Comparisons of retinal thickness between healthy controls and CIS eyes subgroups
Data for the following sections are presented in Table 3 .
Healthy control eyes versus CIS-ON eyes
All OCT parameters except macular inner nuclear layer volume were significantly lower in CIS-ON eyes. pRNFL thickness decrease predominated in temporal quadrant. Thus, we early observed the classical retinal neuro-axonal loss following clinical episode of optic neuritis.
Healthy control eyes versus CIS-NON eyes
MGCIPL volume was significantly lower in CIS-NON eyes. Thus, in CIS patients without past history of optic neuritis, we observed significant retinal neuronal loss but this retinal neuronal loss is lower than after a clinical episode of optic neuritis. Temporal pRNFL thickness and mGCIPL volume were significantly lower in CIS-NON-DIR positive eyes. Thus, in case of asymptomatic optic nerve involvement, we showed the occurrence of an asymptomatic retinal neuro-axonal loss that predominates in temporal quadrant as after a clinical episode of optic neuritis.
Healthy control eyes versus CIS-NON-DIR negative eyes
No significant difference was observed between these two groups. CIS eyes without optic nerve DIR hypersignal did not present significant pRNFL thickness decrease or macular inner retinal layers volumes decrease, or inner nuclear layer volume increase. In Supplementary Table 1 we describe each healthy control group matched to CIS subgroup for comparison.
Comparisons of retinal thickness between different CIS eyes subgroups CIS-ON eyes versus CIS-NON-DIR positive eyes
Temporal pRNFL thickness and mGCIPL volume were significantly lower in CIS-ON eyes. Macular inner nuclear layer volume was significantly higher in CIS-ON eyes. Symptomatic optic nerve DIR hypersignal is associated with more retinal neuro-axonal loss and higher inner nuclear layer thickness than asymptomatic optic nerve DIR hypersignal.
CIS-NON-DIR positive eyes versus CIS-NON-DIR negative eyes
MGCIPL was significantly lower in CIS-NON-DIR positive eyes. Global and temporal RNFL thicknesses were lower in CIS-NON-DIR positive eyes but statistical significance was not reached. No other difference was observed. Asymptomatic optic nerve DIR hypersignal is associated with retinal neuronal loss. Results were unchanged after adjustment to normalized volumes of primary visual cortex (V1) and of T 2 lesion burden within the optic radiations (Supplementary Table 2 ). Normalized V1 volume presented no association with OCT parameters except with mGCIPL volume, but at a lower significance value [b = 0.010 (0.0003 to 0.020), P = 0.042]. Normalized T 2 lesion burden within the optic radiations presented no association with any OCT parameters.
CIS-DIR positive eyes versus CIS-NON-DIR negative eyes
Global and temporal RNFL thicknesses, and mGCIPL volumes were significantly lower in CIS-DIR positive eyes. No other difference was observed. Whether symptomatic or not, an optic nerve DIR hypersignal is associated with retinal neuro-axonal loss. Results were unchanged after adjustment to normalized volumes of primary visual cortex (V1) and T 2 lesion burden within the optic radiations (Supplementary Table 2 ). Normalized T 2 lesion burden within the optic radiations presented no significant association with OCT parameters except with mGCIPL volume, but at a lower significance value [À0.010 (À0.020 to À0.0002), P = 0.046]. Normalized V1 volume presented no association with any OCT parameters. Compared to CIS-NON-DIR negative eyes, LCMVA was lower in CIS-NON-DIR positive eyes [b = 3.07 (À6.42 to 0.28)] but statistical significance was not reached (P 5 0.071). The result was unchanged after adjustment to normalized volumes of primary visual cortex (V1) and T 2 lesion burden within the optic radiations. These two MRI parameters were not associated with LCMVA (Supplementary Table 2 ).
Analysis of visual function in healthy controls and CIS subgroups
Compared to CIS-NON-DIR negative eyes, LCMVA was significantly lower in CIS-DIR positive eyes [b = 8.18 (4.89-11.47); P 5 0.001]. CIS eyes with optic nerve involvement had a worse LCMVA than CIS eyes without. The result was unchanged after adjustment to normalized volumes of primary visual cortex (V1) and T 2 lesion burden within the optic radiations. These two MRI parameters were not associated with LCMVA (Supplementary Table 2 ).
Length and location of optic nerve DIR hypersignal
Within the CIS-DIR positive eye cohort (Table 4) , length of optic nerve DIR hypersignal was significantly associated with all OCT parameters. These associations argued in favour of a greater retinal neuro-axonal loss (P 4 0.001) and a higher macular inner nuclear layer thickness (P = 0.017) when the length of DIR hypersignal increases. For example, a 1 mm increase in length of DIR hypersignal was associated with a 0.89 AE 0.16 mm decrease in global pRNFL. Mean monocular LCMVA score was significantly associated with length of optic nerve DIR hypersignal (P = 0.016) within the CIS-DIR positive eyes cohort. Mean optic nerve DIR lesion length observed in CIS-optic neuritis eyes (n = 24; 13.8 AE 6.7 mm) was significantly (P = 0.047) higher than in CIS-NON-DIR positive eyes (n = 24; 10.0 AE 5.5 mm). Scatterplots of association of optic nerve DIR hypersignal length with OCT parameters in CIS-DIR positive eyes are provided in Supplementary Fig. 7 . We did not find signal abnormalities on chiasma or optic tracts. Thirty-nine patients had involvement of the orbital segment, 14 of the canalicular segment and 10 of the prechiasmatic segment of the optic nerve. Seven eyes had both canalicular and prechiasmatic segments affected. Eight eyes LCMVA is indicated in number of letters correctly identified. b indicates regression coefficient estimated using linear mixed models which corresponds to the mean between-group difference in retinal thicknesses/volume. Significant statistical values (P 5 0.05) are indicated in bold. CI = confidence interval; HC = healthy controls; mINL = macular inner nuclear layer.
had both orbital and canalicular involvement. Four eyes had involvement of the three optic nerve segments. In Table 5 we report the OCT parameters and LCMVA according to presence or absence of DIR hypersignal within each optic nerve segment. Involvement of canalicular segment was associated with a worse visual performance (P = 0.031) and a greater retinal neuronal loss (global pRNFL; P = 0.008). Involvement of others segments was not associated with any parameters. The distribution of symptomatic optic nerve DIR hypersignal among the different orbital, canalicular and prechiasmatic segments of the optic nerve was significantly different (P = 0.020). Optic nerve DIR hypersignal were respectively symptomatic in 48.7%, 78.6% and 30% of the orbital, canalicular and prechiasmatic segments, respectively.
Discussion
In this study, we showed that, first, asymptomatic optic nerve involvement was frequent (31.8% of the whole patient cohort, 36.4% of CIS-ON patients and 29.6% of CIS-NON patients) at an early stage of CIS. Second, we observed retinal neuronal loss in CIS-ON eyes but also to a lesser extent in CIS-NON eyes. Third, retinal neuro-axonal loss was observed in CIS-NON eyes with asymptomatic optic nerve DIR hypersignal, predominantly in the temporal quadrant as after clinical episode of optic neuritis. Asymptomatic optic nerve involvement was associated with retinal neuro-axonal loss independently of demyelinating lesions within the optic radiations and primary visual cortex volume. Fourth, retinal neuro-axonal loss was not observed in CIS-NON eyes without optic nerve DIR hypersignal. Fifth, whether CIS eyes had optic nerve DIR hypersignal or not, and whether symptomatic or not, they presented a significantly lower visual performance compared to healthy control. Symptomatic optic nerve DIR hypersignal was associated with a greater visual disability than asymptomatic optic nerve DIR hypersignal. Finally, the length of optic nerve DIR hypersignal was associated with retinal neuroaxonal loss, visual disability and was higher when optic nerve DIR hypersignal was symptomatic.
As reported in literature, optic neuritis represented one of the major clinical manifestations of CIS in our cohort (Miller et al., 2012) . We detected a symptomatic optic nerve DIR hypersignal in all optic neuritis eyes of CIS patients and showed that one-third of CIS patients also presented asymptomatic optic nerve DIR hypersignal. While optic neuritis is very common in CIS and more than half of our CIS patients have optic nerve lesions whether symptomatic or not, optic nerve lesion is still not included in Table 5 Retinal thickness and volume according to presence or absence of DIR hypersignal within each segment of the optic nerve, in CIS-DIR positive eyes
Involvement of orbital segment Involvement of canalicular segment Involvement of prechiasmatic segment typical demyelinating lesions for spatial dissemination in multiple sclerosis (Thompson et al., 2018) . Not including the optic nerve as a typical location of demyelinating lesion for DIS remains a key problem with current multiple sclerosis diagnostic criteria, especially since it has been shown that inclusion of symptomatic optic nerve involvement in DIS criteria improves the overall performance diagnostic criteria for multiple sclerosis (Brownlee et al., 2018) and that asymptomatic optic nerve involvement was associated with presence of asymptomatic gadolinium-enhanced lesion (London et al., 2018) . We are in need of longitudinal follow-up studies evaluating if demonstration of optic nerve involvement in CIS by clinical examination, OCT, MRI or visual evoked potential may be predictive of conversion to clinically definite multiple sclerosis. We reported asymptomatic optic nerve involvement among CIS-NON eyes (22.2%) in a proportion close to a previous MRI study in CIS (20%; Miller et al., 1988) but interestingly in a lower proportion than in relapsing remitting multiple sclerosis (38.5%; Hadhoum et al., 2016) . If we reported optic nerve DIR hypersignal in more than half of our CIS patients, it remains less than that reported in anatomo-pathological studies focusing on optic nerve lesions in multiple sclerosis. Such anatomo-pathological studies are rare but show almost systematic presence of demyelinating lesions (Toussaint et al., 1983; Mogensen et al., 1990) . However, in our study we focused on an earlier clinical stage of multiple sclerosis. Furthermore, DIR sequence underestimates the frequency of cortical lesions in multiple sclerosis versus anatomo-pathological study (Seewan et al., 2012) . In the same way, optic nerve imaging with 3D-DIR sequence may not be sufficiently sensitive for optimal asymptomatic optic nerve lesion detection. On the other hand, a recent study did not highlight any asymptomatic optic nerve DIR hypersignal among 80 CIS-NON eyes (Puthenparampil et al., 2017) . This could seem surprising considering our previous MRI/OCT study in multiple sclerosis (Hadhoum et al., 2016) as well as studies reporting frequent subclinical visual evoked potential alterations in CIS (Filippi et al., 2018) and multiple sclerosis (Diem et al., 2003) . However, the optic nerve imaging protocol did not primarily include a 3D-DIR sequence, which was performed for cortical plaque imaging; the voxel size was lower and no particular instructions for ocular movements during the 3D-DIR sequence were given to the patient. In the study of Puthenparampil and colleagues, no asymptomatic pRNFL atrophy was reported but macular OCT scan for GCIPL segmentation was not available for comparison.
Confirming previous studies (Trip et al., 2005; Costello et al., 2006; Outteryck et al., 2009) , we showed an early retinal neuro-axonal loss predominating in temporal quadrant after optic neuritis. In the absence of a clinical episode of optic neuritis, we also highlighted retinal neuronal loss at the CIS stage; however, this was limited to mGCIPL and of a lesser extent than after a clinical episode of optic neuritis. Most studies reporting no asymptomatic retinal axonal loss at the CIS stage used Time-Domain (3rd generation) OCT devices (Trip et al., 2005; Outteryck et al., 2009; Kallenbach et al., 2011; Oreja-Guevara et al., 2012) whereas studies reporting asymptomatic retinal neuroaxonal loss or macular inner nuclear layer thickening Oberwahrenbrock et al., 2013; Pérez-Rico et al., 2014; Knier et al., 2016a; Zimmermann et al., 2018) used more recent Spectral-Domain (4th generation) OCT devices, which are more precise and allow one to segment macular retinal layers. OCT device difference is not the unique reason that could explain these conflicting results. Some studies did not include healthy controls (Oreja-Guevara et al., 2012) , and the delay between CIS and inclusion could be sometimes quite large (Trip et al., 2005; Gelfand et al., 2012; Oberwahrenbrock et al., 2013) . If asymptomatic retinal neuro-axonal loss at the CIS stage exists, its amplitude was reported lower than symptomatic retinal neuro-axonal loss Oberwahrenbrock et al., 2013) . Among previous OCT studies in CIS, all but one (Oberwahrenbrock et al., 2013) tried to differentiate among CIS-NON eyes, those with and those without subclinical involvement. The authors made this categorization thanks to visual evoked potentials. Optic nerve imaging has never been reported for such a use. Compared to healthy controls, they showed that CIS-NON eyes without asymptomatic involvement (n = 66; 75% of the CIS cohort) still had a thinner mGCIPL and total macular thicknesses. In our study, retinal thicknesses or volumes of CIS-NON-DIR negative eyes (n = 84; 63.6% of CIS cohort) were comparable to healthy control eyes whereas CIS-NON-DIR positive eyes still presented significant temporal pRNFL and mGCIPL decrease. Interestingly, we observed that in case of asymptomatic optic nerve involvement, pRNFL thickness is predominantly lower in the temporal quadrant as well as after a clinical episode of optic neuritis (Outteryck et al., 2015; Petzold et al., 2017) . The temporal preponderance of pRNFL damage in multiple sclerosis but also in CIS suggestive of multiple sclerosis might be related to a higher sensitivity to injury of parvocellular axons within the optic nerve (Evangelou et al., 2001) . Parvocellular axons are mainly located in papillomacular bundles and constitute a significant part of the temporal peripapillary quadrant.
Thus, we suggest that asymptomatic retinal neuro-axonal loss in CIS may be the consequence of asymptomatic optic nerve lesion rather than the consequence of trans-synaptic degeneration following retrogeniculate injury, and that sensitivity of visual evoked potentials might be lower than DIR sequence for optic nerve demyelinating lesion's detection, as reported recently (Riederer et al., 2019) . Interestingly, CIS-NON-DIR negative eyes presented a slight significant LCMVA decrease and a slight but not significant mGCIPL thinning compared to healthy controls. This could be explained by an undetected asymptomatic optic ways involvement, and particularly by small optic nerve lesions not detected with our MRI protocol. We actually showed that optic nerve hypersignal was significantly smaller in case of asymptomatic optic nerve involvement than in case of clinical episode of optic neuritis. A retrograde trans-synaptic degenerative process well described following occipital lobe damage (Jindahra et al., 2012) and already reported in multiple sclerosis (Gabilondo et al., 2014) might also be discussed in our CIS cohort as a cause of asymptomatic retinal neuro-axonal loss (Puthenparampil et al., 2017) but to a lesser extent than the retrograde degenerative process associated with the asymptomatic optic nerve injury. Furthermore, statistical adjustment to T 2 lesion burden within optic radiations and to primary visual cortex volume did not modify our findings.
Our results are strongly supported by the negative association we observed between the length of optic nerve DIR hypersignal and inner retinal layer thickness or LCMVA, and the positive association observed between the length of optic nerve DIR hypersignal and inner nuclear layer thickness. Length of optic nerve demyelinating lesion on MRI has already been associated to visual disability (Miller et al., 1988; Dunker et al., 1996; Berg et al., 2015; Hadhoum et al., 2016) , retinal inner layer thinning and inner nuclear layer thickening (Hadhoum et al., 2016) . After an optic neuritis episode and particularly after a severe episode, microcystic macular oedema or inner nuclear layer thickening may be observed. Inner nuclear layer thickening is associated with a more pronounced retinal neurodegenerative process (Petzold et al., 2017) and with a higher MRI and clinical activity in multiple sclerosis (Saidha et al., 2012; Knier et al., 2016b Knier et al., , 2017 . Indeed, inner nuclear layer thickening has already been reported in CIS without optic neuritis (Zimmermann et al., 2018) but this study did not include optic nerve MRI and we could hypothesize that inner nuclear layer thickening may be due to asymptomatic optic nerve lesion. In our study, inner nuclear layer thickness and visual disability were higher when optic nerve lesion was symptomatic rather than asymptomatic. We did not highlight any microcystic macular oedema in our cohort. This is in contrast with microcystic macular oedema frequency in neuromyelitis optica spectrum disorders (around 25%) and clinically definite multiple sclerosis (45%) (Saidha et al., 2012; Bennett et al., 2015; Outteryck et al., 2015) . Presence of microcystic macular oedema may be considered a red flag in CIS diagnosis work-up. Confirming previous studies (Miller et al., 1988; Dunker et al., 1996; Kupersmith et al., 2002; Hadhoum et al., 2016) , we suggest that optic nerve inflammatory lesion affecting the canalicular segment may be associated with greater retinal neuronal loss. However, given the small size of eyes subgroups and absence of statistical adjustment, interpretation of this result requires caution. Interestingly, canalicular involvement may be over-represented among symptomatic optic nerve DIR hypersignal.
We acknowledge some limits to our study. This study is exploratory study and we caution that we could not exclude false-positive findings regarding multiple comparisons. Furthermore, we were not able to compare sensitivity of visual evoked potential and DIR sequence for the detection of asymptomatic optic nerve involvement and we did not present exhaustive visual function measurements (i.e. visual field testing, etc). Our CIS cohort is one of the largest reported among OCT studies; however, the sample size remained limited and we caution that we could not exclude that some differences could have been overlooked due to the lack of adequate statistical power. However, our study focused on a homogeneous CIS cohort recruited early after CIS occurrence with a fourth generation OCT analysis coupled to a sensitive optic nerve MRI sequence for demyelinating lesions detection, and we found functional results in line with structural results.
Asymptomatic optic nerve demyelinating lesion is frequent at CIS stage. As well as symptomatic optic nerve lesion is the cause of symptomatic retinal neuro-axonal loss in CIS, asymptomatic optic nerve lesion has to be discussed as the main cause of asymptomatic retinal neuroaxonal loss observed at CIS stage. Our findings clearly suggest that OCT performed at the earliest clinical stage of multiple sclerosis should be considered more as a 'window to the multiple sclerosis optic nerve' rather than a 'window to the multiple sclerosis brain'. Asymptomatic optic nerve lesions have to be taken into account for next OCT studies in CIS and multiple sclerosis.
